• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Best Research Report on Antipsychotic Drugs Market by Forecast to 2027 with Covid-19 Impact, Current and Future Growth Overview, Competitor Analysis | AstraZeneca, Pfizer, Inc., Eli Lily and Co., Bristol- Myers Squibb

November 12th, 2021 Coherent Market Insights Releases

Antipsychotic drugs, often known as neuroleptics or tranquilizers, are a kind of drug that is mostly used to treat schizophrenia or bipolar illness. They are used to treat psychosis, which includes hallucinations, delusions, and paranoid thoughts, among other things. Antipsychotic drugs are useful for treating psychosis in a short period of time. These drugs inhibit dopamine receptors in the brain’s dopaminergic pathways, suppressing the action of dopamine, which is connected directly to psychotic episodes. As the incidence of mental disease has increased, so has the use of antipsychotics. According to the National Alliance of Mental Illness, one in every five individuals suffers from mental illness, accounting for 18.5 % of the overall population suffering from mental problems. Long-term usage of these medicines, on the other hand, may cause adverse effects such as metabolic syndrome and involuntary movement disorder, eventually resulting in an increase in death in the elderly population having dementia.

Get FREE Sample Report with Latest Covid19 Impact Analysis

Increased incidence of mental illness is expected to drive the global antipsychotic drug market growth over the forecast period.

Schizophrenia is the leading cause of psychosis worldwide, and individuals with the condition are more prone to develop physical and mental disorders. According to the World Health Organization, in 2016, around 21 million people in the world were diagnosed with schizophrenia. According to the WHO, one in every two individuals suffering from schizophrenia does not get adequate treatment. This offers an attractive opportunity for global antipsychotic drugs market players to produce cost-effective treatments for the treatment of this condition. Moreover, according to the National Alliance of Medical Illness in 2017, around 1.1 % of the adult population in the U.S. have schizophrenia, while 2.6 % of the country’s population has bipolar disorder. In a particular year, one in every five individuals, or around 43.8 million people, or 18.5 % of the entire population in the U.S., suffers from some form of mental illness. The rising frequency and incidence of neurological diseases are driving the global antipsychotic drug market growth over the forecast period.

Antipsychotic Drug Market Taxonomy:

On the basis of drug type, the global anti-psychotic drugs market is segmented into:

  • First-generation Drugs (Standard / Typical Antipsychotic Agents)
    • Thorazine (Chlorpromazine HCl)
    • Serentil (Mesoridazine Besylate)
    • Mellaril (Thioridazine HCl)
    • Haldol (Haloperidol)
    • Loxitane (Loxapine Succinate)
    • Trilafon (Perphenazine)
    • Navane (Thiothixene)
    • Sordinol (Clopenthixol)
    • Others
  • Second-generation Drugs  (Atypical Antipsychotic Agents)
    • Zyprexa (Olanzapine)
    • Geodon (Ziprasidone)
    • Seroquel (Quetiapine)
    • Risperdal (Risperidone)
    • Clozaril (Clozapine)
    • Invega (Paliperidone)
    • Asendin (Amoxapine)
    • Latuda (Lurasidone)
    • Others
  • Third-generation Drugs
    • Abilify (Aripiprazole)
    • Others

On the basis of application, the global anti-psychotic drugs market is segmented into:

  • Schizophrenia
  • Bipolar Disorder
  • Dementia
  • Unipolar Depression
  • Others

On the basis of distribution channel, the global anti-psychotic drugs market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Get PDF Brochure with Latest Insights

North America is expected to account for the largest share in the global antipsychotic drug market due to the growing number of people suffering from mental illnesses.

Geographically, the global antipsychotic drugs market is divided into Europe, North America, Asia Pacific, Latin America, Africa, and the Middle East. North America has the highest market share in the global antipsychotic drugs market, owing to an increase in the incidence of psychosis among the youth population as well as a rising incidence of schizophrenia among the elderly population. According to the National Academy of Mental Illness sociological statistics from 2017, around 70% of youth in the juvenile justice system in the U.S. have at least one mental health problem, with around 20% having a severe mental problem. Due to government attempts to enhance treatment for a growing number of individuals suffering from mental illness, Asia Pacific is expected to witness substantial growth in the global antipsychotic drugs market over the forecast period. According to the World Health Organization (WHO), Pilot Programs in India, Pakistan, and Iran have demonstrated suitability in delivering healthcare to persons with mental health disorders, such as the supply of appropriate medicines and awareness programs to reduce stigma and discrimination associated with mental illness.

Increased drug abuse and the prevalence of drug addiction are inadvertently driving the global antipsychotic drugs market growth over the forecast period.

Rising incidence of schizophrenia and psychotic illnesses is a significant driver of the global antipsychotic drug market. Several additional causes, such as the rising prevalence of drug abuse, overprescribing of psychotic medications, and addictions to antipsychotic drugs, also contribute to the global antipsychotic drugs market growth over the forecast period. According to the National Survey on Drug Use and Health (NSDUH), around 13.2 5 of the U.S. population (around 4 million persons) was using an illegal drug or abused a psychotherapeutic drug in 2012. However, the recent patent expiration of key brands has had an adverse impact on the global antipsychotic drugs market growth over the forecast period. Furthermore, the adverse effects of antipsychotics, which cause insomnia, tardive dyskinesia, and a variety of other problems, are limiting the global antipsychotic drugs market growth over the forecast period.

Major players are concentrating on the development of new and innovative therapeutic drugs in order to improve their position in the global antipsychotic drugs market.

Some of the major players contributing to the global antipsychotic drugs market include Bristol- Myers Squibb, Eli Lily and Co., GlaxoSmithKline, AstraZeneca, Allergen, Johnson & Johnson, and Pfizer, Inc. These players are active in the development of new medications for the treatment of psychotic illnesses with fewer adverse effects in order to boost the demand for the product in the market. Otsuka Pharmaceuticals obtained the U.S. Food and Drug Administration (FDA) approval in November 2017 for Abilify MyCite, the first antipsychotic medication therapy, which is infused with a computerized ingestion tracking system and is intended to treat Schizophrenia and acute bipolar disorder attacks.

Purchase This Premium Report To Access Full Information

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Antipsychotic Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Antipsychotic Drugs Industry Impact

Chapter 2 Global Antipsychotic Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antipsychotic Drugs (Volume and Value) by Type
2.3 Global Antipsychotic Drugs (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Antipsychotic Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Antipsychotic Drugs Market Analysis
Chapter 6 East Asia Antipsychotic Drugs Market Analysis
Chapter 7 Europe Antipsychotic Drugs Market Analysis
Chapter 8 South Asia Antipsychotic Drugs Market Analysis
Chapter 9 Southeast Asia Antipsychotic Drugs Market Analysis
Chapter 10 Middle East Antipsychotic Drugs Market Analysis
Chapter 11 Africa Antipsychotic Drugs Market Analysis
Chapter 12 Oceania Antipsychotic Drugs Market Analysis
Chapter 13 South America Antipsychotic Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Antipsychotic Drugs Business
Chapter 15 Global Antipsychotic Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email